
Acute myelogenous leukemia - Symptoms and causes - Mayo Clinic
Dec 20, 2024 · Acute myelogenous leukemia, also called AML, is a cancer of the blood and bone marrow. Bone marrow is the soft matter inside bones where blood cells are made. The word "acute" …
Acute myeloid leukemia - Wikipedia
Between 2017 and 2025, 12 new agents have been approved for AML in the U.S., including venetoclax (BCL2 inhibitor), gemtuzumab ozogamicin (CD33 antibody-drug conjugate), and several inhibitors …
Acute Myeloid Leukemia (AML): Symptoms, Treatment & Prognosis
Mar 21, 2023 · Acute myeloid leukemia (AML) is a rare cancer that affects your bone marrow and blood. AML typically affects people age 65 and older, but it can affect children and teenagers.
What Is Acute Myeloid Leukemia (AML)? - American Cancer Society
Acute myeloid leukemia (AML) starts in the bone marrow, the soft inner part of certain bones, where new blood cells are made. Most often AML quickly moves from the bone marrow into the blood.
Acute Myeloid Leukemia Treatment - NCI
May 16, 2025 · Adult acute myeloid leukemia (AML) is a type of cancer in which the bone marrow makes a large number of abnormal blood cells. AML is a cancer of the blood and bone marrow. It is the …
Acute Myeloid Leukemia (AML) - MD Anderson Cancer Center
Acute myeloid leukemia is a type of cancer that affects myeloid stem cells, which produce red blood cells, platelets and granulocytes, a type of white blood cell. Learn about the causes, symptoms and …
Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk‐Stratification ...
Acute myeloid leukemia (AML) is a bone marrow stem cell cancer that is often fatal despite available treatments.
The global epidemiology of acute myeloid leukaemia - Nature
Dec 5, 2025 · The global incidence of acute myeloid leukaemia (AML) has increased substantially over the past three decades, largely reflecting population ageing, improved diagnostics and enhanced …
Acute Myelogenous Leukemia: Kimmel Cancer Center
Acute Myeloid Leukemia (AML) is a type of blood cancer that starts in the bone marrow, the spongy tissue inside our bones, where blood cells are made. In AML, immature blood cells called myeloid …
AML: Clinical Data Confirms Lower Survival in Black Patients
Dec 7, 2025 · Cytogenetic risk doesn't seem to explain the disparity in mortality of Black vs White patients, a study across 10 clinical trials suggests.